Nextorage has released a new line of CFexpress Type A cards. But what makes these Type A cards specials is they conform to ...

"Gene editing is a promising, complex technology, which will take many years to develop into a therapy for people with CF," ...

BOSTON, Nov. 18, 2024 /PRNewswire/ -- Sionna Therapeutics, a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by ...